Pandemic Spurred Increase In Screen Time Among Children, Teens
via HealthDayTHURSDAY, April 2, 2026 — The COVID-19 pandemic fueled a dramatic rise in screen use among children and teenagers, a new evidence review says.
Kids spent more time with screens after the pandemic, using computers, video games, smartphones and tablets at rates higher than before COVID struck, researchers recently reported in the journal Clinical Child Psychology and Psychiatry.
Only television has declined as a means of screen entertainment among children and teens, researchers found.
“Interestingly, even during the pandemic, television viewing continued to decline,” co-lead investigator Yuko Mori said in a news release. She’s a postdoctoral researcher at the University of Turku Research Center for Child Psychiatry in Finland.
For the study, researchers analyzed 60 studies conducted between 1991 and 2022 on screen use among children aged 19 and younger.
Prior to the pandemic, results were mixed regarding screen use. Some showed screen use increasing, while others showed stable or decreasing trends depending on the device in question.
But after the pandemic, there was a dramatic increase in both total and leisure screen time among children and teens.
Older children and teens generally reported higher screen time than younger kids, the study found.
“This likely reflects developmental factors,” said co-lead author Sanju Silwal, a postdoctoral researcher at the University of Turku. “Adolescence is a life stage where peer relationships, online social interaction and romantic relationships become increasingly central.”
The review specifically found:
Researchers are concerned that more time spent with screens could harm the physical and mental health of children.
Screen time might affect their sleep and could expose them to cyberbullying, inappropriate content and unrealistic body ideals, researchers said.
“Technology offers tremendous opportunities, but it also presents risks,” Silwal said. “To ensure that children benefit from digital environments, we need continuous research, evidence-based policies and coordinated efforts from families, schools, communities and governments.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-03 01:52
Read more
- ACC: Hypertensive Heart Disease Mortality Increasing in Young Women
- Chiesi Global Rare Diseases Announces FDA Approval of Juxtapid (lomitapide) Capsules for Pediatric Use in Homozygous Familial Hypercholesterolemia (HoFH)
- Bees and Hummingbirds May Be Consuming Small Amounts of Alcohol
- Previous COVID-19 Tied to Increased Risk for Kidney Disease
- Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease
- Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. Approval for Opdivo (nivolumab)
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions